Minnesota FOIA #P007525804

Minnesota Regenerative Medicine Partnership – RGS Inhibition For Treatment of Obesity, Diabetes, Nash and Cardiometab...

This purchase order from the Twin Cities government agency awarded to Mayo Clinic for $397,500 on October 4, 2021, covers a contract for the Minnesota Regenerative Medicine Partnership focusing on RGS inhibition for treating obesity, diabetes, Nash, and cardiometabolic disorders. The order involves Mayo Clinic as the vendor, located in Minneapolis, Minnesota, with the purchase being a single lot. The procurement is related to medical research and treatment development, with Mayo Clinic identified as the recipient and vendor. The award is categorized under 'state' due to the Minnesota government agency, with the country code 'US' and jurisdiction 'MN'. The location is Minneapolis, MN, and the primary contact details are not specified. Likely competitors for similar awards include other major medical research institutions and healthcare providers.

Description

Minnesota Regenerative Medicine Partnership – RGS Inhibition For Treatment of Obesity, Diabetes, Nash and Cardiometabolic Disorders